EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation

Alexandre Sitbon iD, Pierre-Romain Delmotte, Valéria Pistorio, Sébastien Halter, Jérémy Gallet, Jérémie Gautheron, Antoine Monsel

Journal of Translational Medicine · 2024

DOI: 10.1186/s12967-024-05282-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Translational Medicine, 2024. Verfasst von Alexandre Sitbon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Vesicles, Immunomodulation, Translational Research, Biomedical. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation plays a critical role in conditions such as acute liver failure, acute-on-chronic liver failure, and ischemia–reperfusion-induced liver injury. Various pathogenic pathways contribute to liver inflammation, involving inflammatory polarization of macrophages and Küpffer cells, neutrophil infiltration, dysregulation of T cell subsets, oxidative stress, and activation of hepatic stellate cells. While mesenchymal stromal cells (MSCs) have demonstrated beneficial properties, their clinical translation is limited by their cellular nature. However, MSC-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapeutic approach for immunomodulation. MSC-EVs naturally mirror their parental cell properties, overcoming the limitations associated with the use of MSCs. In vitro and in vivo preclinical studies have demonstrated that MSC-EVs replicate the beneficial effects of MSCs in liver injury. This includes the reduction of cell death and oxidative stress, improvement of hepatocyte function, induction of immunomodulatory effects, and mitigation of cytokine storm. Nevertheless, MSC-EVs face challenges regarding the necessity of defining consistent isolation methods, optimizing MSCs culture conditions, and establishing quality control measures for EV characterization and functional assessment. By establishing standardized protocols, guidelines, and affordable cost mass production, clinicians and researchers will have a solid foundation to conduct further studies, validate the therapeutic efficacy of MSC-EVs, and ultimately pave the way for their clinical implementation in acute liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsExtracellular VesiclesImmunomodulationTranslational Research, BiomedicalHumansAnimalsAcute DiseaseInflammationHepatitis

Stichwörter der Autor:innen

Acute liver failureAcute-on-chronic liver failureExosomesExtracellular vesiclesImmunomodulationIschemia–reperfusion injuryMesenchymal stromal cellsTranslational Medicine

Autor:innen und Institutionen

  • Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France. alex.sitbon@gmail.c…
  • Sorbonne Université, INSERM UMRS-938, Centre de Recherche de Saint-Antoine (CRSA), 75012, Paris, France. alex.sitbon@gmail.com.
  • Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.
  • Sorbonne Université, INSERM UMRS-938, Centre de Recherche de Saint-Antoine (CRSA), 75012, Paris, France.
  • Sorbonne Université, INSERM UMRS-959, Immunology-Immunopathology-Immunotherapy (I3), 75013, Paris, France.

ORCID-Profile: Alexandre Sitbon

Zitieren

APA

Sitbon, A., Delmotte, P. R., Pistorio, V., Halter, S., Gallet, J., Gautheron, J., & Monsel, A. (2024). Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation. Journal of Translational Medicine. https://doi.org/10.1186/s12967-024-05282-9

Vancouver

Sitbon A, Delmotte PR, Pistorio V, Halter S, Gallet J, Gautheron J, et al. Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation. Journal of Translational Medicine. 2024. doi:10.1186/s12967-024-05282-9

BibTeX
@article{Sitbon2024,
  author = {Sitbon, Alexandre and Delmotte, Pierre-Romain and Pistorio, Valéria and Halter, Sébastien and Gallet, Jérémy and Gautheron, Jérémie and Monsel, Antoine},
  title = {Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation},
  journal = {Journal of Translational Medicine},
  year = {2024},
  doi = {10.1186/s12967-024-05282-9}
}
Kostenlos starten →